[1]
|
E. J. Bow, M. G. Kilpatrick and J. J. Clinch, “Totally Implantable Venous Access Ports Systems for Patients Receiving Chemotherapy for Solid Tissue Malignancies: A Randomized Controlled Clinical Trial Examining the Safety, Efficacy, Costs, and Impact on Quality of Life,” Journal of Clinical Oncology, Vol. 17, No. 4, 1999, p. 1267.
|
[2]
|
S. Kurul, P. Saip and T. Aydin, “Totally Implantable Venous-Access Ports: Local Problems and Extravasation Injury,” Lancet Oncology, Vol. 3, No. 11, 2002, pp. 684692. doi:10.1016/S1470-2045(02)00905-1
|
[3]
|
R. O. Hickman, C. D. Buckner, R. A. Clift, J. E. Sanders, P. Stewart and E. D. Thomas, “A Modified Right Atrial Catheter for Access to the Venous System in Marrow Transplant Recipients,” Surg Gynecol Obstet, Vol. 148 No. 6, 1979, pp. 871-875.
|
[4]
|
J. M. Estes, R. Rocconi, J. M. Straughn, S. Bhoola, C. A. Leath, R. D. Alvarez, L. C. Kilgore and W. K. Huh, “Complications of Indwelling Venous Access Devices in Patients with Gynecologic Malignancies,” Gynecologic Oncology, Vol. 91.No. 3, 2003, pp. 591-595.
doi:10.1016/j.ygyno.2003.08.015
|
[5]
|
R. E. Schwarz, J. S. Groeger and D. G. Coit, “Subcutaneous Implanted Central Venous Access Devices in Cancer Patients: A Prospective Analysis,” Cancer, Vol. 79, No. 8, 1997, pp. 1635-1640.
doi:10.1002/(SICI)1097-0142(19970415)79:8<1635::AID-CNCR30>3.0.CO;2-X
|
[6]
|
S. Ruesch, B. Walder and M. R. Tramer, “Complications of Central Venous Catheters: Internal Jugular Versus Subclavian Access-Asystematic Review,” Critical Care Medicine, Vol. 30, No. 2, 2002, pp.454-460.
doi:10.1097/00003246-200202000-00031
|
[7]
|
L. K. Jablon, K. R. Ugolini and N. C. Nahmias, “Cephalic Vein Cut-Down Verses Percutaneous Access: A Retrospective Study of Complications of Implantable Venous Access Devices,” American Journal of Surgery, Vol. 192, No. 1, 2006, pp. 63-67.
doi:10.1016/j.amjsurg.2005.11.012
|
[8]
|
P. F. Mansfield, D. C. Hohn, B. D. Fornage, M. A. Gregurich and D. M. Ota, “Complications and Failures of Subclavian-Vein Catheterization,” New England Journal of Medicine, Vol. 331, No. 26, 1994, pp. 1735-1738.
doi:10.1056/NEJM199412293312602
|
[9]
|
C. Ballarini, M. Intra, A. P. Ceretti, A. Cordovana, P. Papani, G. Farina, S. Perrone, M. Tomirotti, A. Scanni and G. P. Spina, “Complications of Subcutaneous Infusion Port in the General Oncology Population,” Oncology, Vol. 56, No. 2, 1999, pp. 97-102.
|
[10]
|
H. M. Chang, H. F. Hsieh, S. D. Hsu, G. S. Liao, C. H. Lin, C. B. Hsiehand J. C. Yu, “Guidewire Assisted Cephalic Vein Cutdown for Insertion of Totally Implantable Access Ports,” Journal of Surgical Oncology, Vol. 95, No. 2, 2007, pp. 156-157. doi:10.1002/jso.20584
|
[11]
|
S. P. Povoski, “A Prospective Analysis of the Cephalic Vein Cutdown Approach for Chronic Indwelling Central Venous Access in 100 Consecutive Cancer Patients,” Annals of Surgical Oncology, Vol. 7, No. 7, 2000, pp. 496-502. doi:10.1007/s10434-000-0496-9
|
[12]
|
F. A. D’Angelo, G. Ramacciato, R. A. P De Angelis, P. Amodio, M. Magri and P. Barillari, “Prospective Randomised Study of Cephalic Vein Cut-Down versus Subclavian Vein Puncture Technique in the Implantation of Subcutaneous Venous Access Devices,” Chirurgia Italiana, Vol. 54, No.4, 2002, pp.495-500.
|
[13]
|
C. M. Seiler, B. E. Frohlich, U. J. Dorsam, P. Kienle, M. W. Buchler and H. P. Knaebel, “ Surgical Technique for Totally Implantable Access Ports (TIAP) Needs Improvement: A Multivariate Analysis of 400 Patients,” Journal of Surgical Oncology, Vol. 93, No. 1, 2006, pp. 24-29.
doi:10.1002/jso.20410
|
[14]
|
P. Knebel, L. Fischer, J. Huesing, R. Hennes, M. W. Buchler and C. M. Seiler, “Randomized Clinical Trial of a Modified Seldinger Technique for Open Central Venous Cannulation for Implantable Access Devices,”British Journal of Surgery, Vol. 96, No. 2, 2009, pp. 159-165.
doi:10.1002/bjs.6457
|
[15]
|
R. L. Poorter, F. N. Lauw, W. A. Bemelman, P. J. M. Bakker, C. W. Taat and C. H. N. Veehof, “Complications of an Implantable Venous Access Device (Port-a-Cath) during Intermittent Continuous Infusion of Chemotherapy,” European Journal of Cancer, Vol. 32, No. 13, 1996, pp. 2262-2266. doi:10.1016/S0959-8049(96)00274-2
|
[16]
|
N. Wolosker, G. Yazbek, M. A. Munia, A. E. Zerati, M. Langer and K. Nishinari, “Totally Implantable Femoral Vein Catheters in Cancer Patients,” European Journal of Surgical Oncology, Vol. 30, No. 7, 2004, pp. 771-775.
|
[17]
|
S. Y. Chen, C. H. Lin, H. M. Chang, H. M. Hsu and J. C. Yu, “A Safe and Effective Method to Implant a Totally Implantable Access Port in Patients With Synchronous Bilateral Mastectomies: Modified Femoral Vein Approach,” Journal of Surgical Oncology, Vol. 98, No. 3, 2008, pp. 197-199. doi:10.1002/jso.21048
|
[18]
|
L. M. Perlmutt, W. W. Johnston and N. R. Dunnick, “Percutaneous Transthoracic Needle Aspiration: A Review,” American Journal of Roentgenology, Vol. 152, No. 3, 1989, pp. 451-455.
|
[19]
|
P. A. Rubio and E. M. Farrell, “Percutaneous Infraclavicular Subclavian Catheterization,” American Journal of Surgery, Vol. 48, No. 5, 1982, pp. 230-231.
|
[20]
|
S. L. Morris, P. F. Jaques and M. A. Mauro, “RadiologyAssisted Placement of Implantable Subcutaneous Infusion Ports for Long-Term Venous Access,” Radiology, Vol. 184, 1992, pp. 149-151.
|
[21]
|
B. Gebauer, M. El-Sheik, M. Vogt and H. J. Wagner, “Combined Ultrasound and Fluoroscopy Guided Port Catheter Implantation-High Success and Low Complication Rate,” European Journal of Radiology, Vol. 69, No. 3, 2009, pp. 517-522. doi:10.1016/j.ejrad.2007.10.018
|
[22]
|
P. Y. Marcy, N. Magne, P. Castadot, C. Bailet, J. C. Macchiavello, M. Namer and J. C. Gaard, “Radiological and Surgical Placement of Port Devices: A 4-Year Institutional Analysis of Procedure Performance, Quality of Life and Cost in Breast Cancer Patients,” Breast Cancer Research and Treatment, Vol. 92, No. 1, 2005, pp. 61-67.
doi:10.1007/s10549-005-1711-y
|
[23]
|
H. M. Chang, C. B. Hsieh, H. F. Hsieh, T. W. Chen, C. J. Chen, D. C. Chan, J. C. Yu, Y. C. Liu and K. L. Shen, “An Alternative Technique for Totally Implantable Central Venous Access Devices. A Retrospective Study of 1311 Cases,” European Journal of Surgical Oncology, Vol. 32, No. 1, 2006, pp. 90-93.
|
[24]
|
W. Zingg, A. Imhof, M. Maggiorini, R. Stocker, E. Keller and C. Ruef, “Impact of a Prevention Strategy Targeting Hand Hygiene and Catheter Care on the Incidence of Catheter-Related Bloodstream Infections,” Critical Care Medicine, Vol. 37, No. 7, 2009, pp. 2167-2173.
doi:10.1097/CCM.0b013e3181a02d8f
|
[25]
|
D. G. Maki, M. Ringer and C. J. Alvarado, “Prospective randomised Trial of Povidone-Iodine, Alcohol, and Chlorhexidine for Prevention of Infection Associated with Central Venous and Arterial Catheters,” Lancet, Vol. 338, No. 8763, 1991, pp. 339-343.
doi:10.1016/0140-6736(91)90479-9
|
[26]
|
A. W. Allen, J. L.Megargell, D. B. Brown, F. C. Lynch, Y. Singh and P. N. Waybill, “Venous Thrombosis Associated with the Placement of Peripherally Inserted Central Catheters,” Journal of Vascular and Interventional Radiology, Vol. 11, No. 10, 2000, pp. 1309-1314.
doi:10.1016/S1051-0443(07)61307-4
|
[27]
|
R. Biffi, F. Corrado, F. de Braud, F. de Lucia, D. Scarpa, A. Testori, F. Orsi, M. Bellomi, S. Mauri, M. Aparo and B. Andreoni, “Long Term, Totally Implantable Central Venous Access Ports Connected to Groshong Catheter for Chemotherapy of Solid Tumours: Experience on 178 Cases Using a Single Type of Device,” European Journal of Cancer, Vol. 33, No. 8, 1997, pp. 1190-1194.
doi:10.1016/S0959-8049(97)00039-7
|
[28]
|
D. H. Hinke, D. A. Zandt-Stastny, L. R. Goodman, E. J. Quebbeman, E. A. Krzywda and D. A. Andris, “Pinch-Off Syndrome: A Complication of Implantable Subclavian Venous Access Devices,” Radiology, Vol. 177, No. 2, 1990, pp. 353-356.
|